BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 17635947)

  • 1. Reevaluation of the combined dexamethasone suppression-corticotropin-releasing hormone test for differentiation of mild cushing's disease from pseudo-Cushing's syndrome.
    Gatta B; Chabre O; Cortet C; Martinie M; Corcuff JB; Roger P; Tabarin A
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4290-3. PubMed ID: 17635947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone-suppressed corticotropin-releasing hormone stimulation test for diagnosis of mild hypercortisolism.
    Erickson D; Natt N; Nippoldt T; Young WF; Carpenter PC; Petterson T; Christianson T
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2972-6. PubMed ID: 17488798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests.
    Alwani RA; Schmit Jongbloed LW; de Jong FH; van der Lely AJ; de Herder WW; Feelders RA
    Eur J Endocrinol; 2014 Apr; 170(4):477-86. PubMed ID: 24394725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M; Elias LL; Elias PC; Moreira AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the dexamethasone-suppressed corticotropin-releasing hormone test and low-dose dexamethasone suppression test in the diagnosis of Cushing's syndrome.
    Martin NM; Dhillo WS; Banerjee A; Abdulali A; Jayasena CN; Donaldson M; Todd JF; Meeran K
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2582-6. PubMed ID: 16670165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of CRH stimulation test and overnight 8 mg dexamethasone suppression test in 469 patients with ACTH-dependent Cushing's syndrome.
    Detomas M; Ritzel K; Nasi-Kordhishti I; Wolfsberger S; Quinkler M; Losa M; Tröger V; Kroiss M; Fassnacht M; Vila G; Honegger JB; Reincke M; Deutschbein T
    Front Endocrinol (Lausanne); 2022; 13():955945. PubMed ID: 36277711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The application of the combined corticotropin-releasing hormone plus desmopressin stimulation during petrosal sinus sampling is both sensitive and specific in differentiating patients with Cushing's disease from patients with the occult ectopic adrenocorticotropin syndrome.
    Tsagarakis S; Vassiliadi D; Kaskarelis IS; Komninos J; Souvatzoglou E; Thalassinos N
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2080-6. PubMed ID: 17356045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dexamethasone-suppressed corticotrophin-releasing hormone stimulation test in anorexia nervosa.
    Duclos M; Corcuff JB; Roger P; Tabarin A
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):725-31. PubMed ID: 10619977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
    Newell-Price J; Perry L; Medbak S; Monson J; Savage M; Besser M; Grossman A
    J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACTH after 15 min distinguishes between Cushing's disease and ectopic Cushing's syndrome: a proposal for a short and simple CRH test.
    Ritzel K; Beuschlein F; Berr C; Osswald A; Reisch N; Bidlingmaier M; Schneider H; Honegger J; Geyer LL; Schopohl J; Reincke M
    Eur J Endocrinol; 2015 Aug; 173(2):197-204. PubMed ID: 25953828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC; Raff H; Findling JW
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    Newell-Price J; Morris DG; Drake WM; Korbonits M; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1640-5. PubMed ID: 11932295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparing overnight dexamethasone suppression test, urine free cortisol, and midnight serum cortisol for the initial diagnosis of Cushing' s syndrome].
    Tang TJ; Liu YP; Yu YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):764-8. PubMed ID: 24325108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The discriminatory value of the low-dose dexamethasone suppression test in the investigation of paediatric Cushing's syndrome.
    Dias R; Storr HL; Perry LA; Isidori AM; Grossman AB; Savage MO
    Horm Res; 2006; 65(3):159-62. PubMed ID: 16514243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.